NASDAQ · Biotechnology

CBUS (CBUS) Stock

$1.93 +0.00% NASDAQ: CBUS Healthcare

Valuation

MetricValue
Price$1.93
Market Cap$87.79M
P/E Ratio-0.50
P/B Ratio2.85
P/S Ratio14.65
EPS (TTM)$0.00
52-Week High$4.19
52-Week Low$1.09
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-577.27%
ROA-41.64%
ROCE-304.55%
Gross Margin-1675.00%
Operating Margin-1675.00%
Net Margin-23.66%
Debt/Equity7.78
Current Ratio0.71

Annual Financials (USD)

Metric20212022202320242025
Revenue$26.0M$0$2.0M$4.0M$4.0M
Operating Profit$-29.0M$-22.0M$-319.0M$-258.0M$-67.0M
Net Profit$-29.0M$-17.0M$-268.0M$-251.0M$-127.0M
EPS$-0.05$-0.03$-25.95$-10.83$-2.78
Op Margin-112.9%-14248.4%-17550.0%-6062.8%-1853.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$37.0M$22.0M$544.0M$350.0M$305.0M
Total Liabilities$23.0M$15.0M$206.0M$252.0M$283.0M
Cash$14.0M$3.0M$33.0M$14.0M$10.0M
Borrowings$18.0M$14.0M$25.0M$36.0M$268.0M

Latest News

Cibus (CBUS) Welcomes Landmark EU Crop Breeding Decision Insider Monkey · Jul 14, 2026 Europe Recognizes Nature-Based Plant Improvement, Opening a New Pathway for Cibus GlobeNewswire · Jun 17, 2026 Cibus Names Agricultural Biotechnology Leader Craig Wichner as Chief Executive Officer to Accelerate Growth and Value Creation GlobeNewswire · Jun 8, 2026 Cibus, Inc. Q1 2026 Earnings Call Summary Moby · May 15, 2026 Cibus Inc (CBUS) Q1 2026 Earnings Call Highlights: Strategic Advances Amid Financial Challenges GuruFocus.com · May 15, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-19.0M$-19.0M$-46.0M$-58.0M$-51.0M
Investing Cash Flow$11.0M$-3.0M$51.0M$-2.0M$-1.0M
Financing Cash Flow$0$-1.0M$2.0M$-2.0M$0
Net Cash Flow$-4.0M$-11.0M$29.0M$-18.0M$-5.0M
Free Cash Flow$-19.0M$-21.0M$-51.0M$-59.0M$-51.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-80.69%
Quick Ratio2.37
Interest Coverage-1.91
Return 1Y42.36%
Return 3Y-89.11%
Return 5Y-98.90%

Ownership

Insiders Held26.13%
Institutions Held33.63%
Institutions Float Held45.52%
Institutional HolderSharesReport Date
FMR, LLC11,425,9292026-03-31
Vanguard Capital Management LLC2,118,4962026-03-31
Davidson Kempner Capital Management LP1,527,6062026-03-31
Vantage Consulting Group, Inc1,143,9492025-12-31
Weiss Asset Management Lp888,1242026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACRV $1.73 +2.37% -0.95 $74.05M 0.00%
BMEA $1.22 +0.00% -1.20 $88.21M 0.00%
CAMP $3.47 +6.12% -1.70 $73.70M 0.00%
IMUXImmunic, Inc. $13.81 +3.14% -2.24 $188.11M 0.00%
MNOV $1.31 -0.76% -5.75 $64.48M 0.00%

About CBUS

CBUS is led by CEO Peter R. Beetham, employs 157 people, headquartered in US, publicly traded since 2017.

CBUS stock trades at $1.93 with a market capitalization of $87.79M. The stock is valued at a price-to-earnings (P/E) ratio of -0.50, price-to-book of 2.85, price-to-sales of 14.65. Over the past 52 weeks the stock has ranged between $1.09 and $4.19, and currently trades 53.9% below its 52-week high.

On profitability, CBUS generates a return on equity (ROE) of -577.27%, return on capital employed of -304.55%, an operating margin of -1675.00%, a net profit margin of -23.66%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides